一线F-胆PET/CT治疗原发性甲状腺功能障碍症:来自诊断随机的APACH2试验的成本效益研究
Elske Quak1, Audrey Lasne-Cardon2, Marie Cavarec3
1Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Caen, France. e.quak@baclesse.unicancer.fr.
European journal of nuclear medicine and molecular imaging
|January 6, 2026
概括
第一线[18F]F-胆PET/CT比[99mTc]Tc-sesta MIBI SPECT/CT更有效治疗原发性甲状腺功能障碍症,使更多患者能够接受成功的微创甲状腺切除术,成本仅略有增加.
科学领域:
- 核医学就是核医学.
- 放射性药物 放射性药物 放射性药物
- 手术管理的手术管理.
背景情况:
- APACH2试验证明了[18F]F-胆 (FCH1) PET/CT对[99mTc]Tc-sesta MIBI (MIBI1) SPECT/CT的优越性,用于指导原发性副甲状腺症 (pHPT) 手术.
- 这项研究旨在评估与MIBI1.1相比,优越的FCH1成像策略的成本效益.
研究的目的:
- 为了确定使用一线[18F]F-胆PET/CT与[99mTc]Tc-sesta MIBI SPECT/CT用于原发性副甲状腺症患者的增量成本效益比率 (ICER).
- 从付款人的角度来看,评估FCH1成像的临床收益与其增加的成本相比.
主要方法:
- 一个随机控制的多中心试验 (APACH2),比较FCH1和MIBI1成像策略.
- 通过手术后一个月的正常血症率来衡量有效性.
- 医疗经济分析综合直接医院费用长达六个月,计算ICER并进行敏感性分析.
主要成果:
- 与MIBI1 (p=0.037) 相比,FCH1策略的有效率差异为29% (85%对56%).
- 平均成本差异为136.5欧元,FCH1的ICER为471欧元,表明治疗一个额外的患者的成本.
- 灵敏度分析证实FCH1的价格略高,但更有效.
结论:
- 第一线[18F]F-胆PET/CT促进了更多的pHPT患者直接转诊,以获得成功的最小侵入性副甲状腺切除术.
- 从医疗保险的角度来看,这种改进的外科管理是以最小的额外成本实现的.
更多相关视频
08:02Author Spotlight: Enhanced Quantification of Cardiovascular Calcification Progression for Longitudinal Micro PET/CT Studies in Small Research Animals
Published on: November 15, 2024
950
08:07Procurement of Parathyroid Glands from Living Donor Pigs and Ex Vivo Identification
Published on: August 1, 2025
1.1K
相关概念视频
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
381
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
381
01:29Positron Emission Tomography
6.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.9K